Bortero Injection Bortezomib 3.5mg

Bortero injection, which contains Bortero Injection Bortezomib 3.5mg, is a highly effective medicine used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to the class of drugs called proteasome inhibitors, which work by disrupting the process of protein degradation in cells, leading to cancer cell death.

Bortezomib inhibits the proteasome, a protein complex responsible for breaking down unnecessary or damaged proteins in cells. By blocking this process, it causes the accumulation of proteins in cancer cells, leading to stress and apoptosis (programmed cell death).

• Multiple myeloma: A type of blood cancer affecting plasma cells.
• Mantle cell lymphoma: A rare and aggressive type of non-Hodgkin lymphoma.

Bortero Injection Bortezomib 3.5mg is supplied as a lyophilized powder for injection, which is administered via intravenous (IV) or subcutaneous (SC) routes. The dosage depends on the patient’s condition, body surface area, and treatment protocol. It is administered under the supervision of a qualified healthcare professional.

• Fatigue
• Nausea
• Diarrhea
• Peripheral neuropathy (tingling or numbness in hands and feet)
• Low blood counts, including anemia and thrombocytopenia

• Store at a temperature below 25°C, away from light and moisture. 
• Reconstitute only with sterile water for injection.

Patients with liver or kidney problems should use Bortero with caution. Regular monitoring of blood counts and organ function is necessary to effectively manage side effects.

Bortero Injection Bortezomib 3.5mg is a reliable option for targeted cancer treatment, providing a proven mechanism to fight specific malignant diseases.

Check this Anti Cancer product Borteshil 2mg Injection or you may explore more Anti Cancer products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.